MORGAN STANLEY - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 96 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$906,222
-47.5%
1,022,825
-6.9%
0.00%
Q3 2022$1,725,000
-71.1%
1,098,967
-63.0%
0.00%
-100.0%
Q2 2022$5,972,000
-21.9%
2,972,031
-9.4%
0.00%0.0%
Q1 2022$7,645,000
+80.0%
3,281,214
+259.2%
0.00%0.0%
Q4 2021$4,247,000
-35.4%
913,501
+6.1%
0.00%0.0%
Q3 2021$6,572,000
-25.7%
861,269
-5.7%
0.00%0.0%
Q2 2021$8,851,000
+32.8%
913,309
+13.3%
0.00%0.0%
Q1 2021$6,667,000
-49.8%
805,985
-58.6%
0.00%
-50.0%
Q4 2020$13,294,000
-56.5%
1,947,893
-29.0%
0.00%
-66.7%
Q3 2020$30,580,000
+444.7%
2,742,494
+206.8%
0.01%
+500.0%
Q2 2020$5,614,000
+2330.3%
893,876
+606.9%
0.00%
Q1 2020$231,000
-74.1%
126,456
-52.1%
0.00%
Q4 2019$892,000
+350.5%
263,854
+183.4%
0.00%
Q3 2019$198,000
+61.0%
93,106
+103.1%
0.00%
Q2 2019$123,000
-81.2%
45,841
-66.7%
0.00%
Q1 2019$654,000
-87.6%
137,606
-93.7%
0.00%
-100.0%
Q4 2018$5,258,000
+303.8%
2,190,901
+639.9%
0.00%
Q3 2018$1,302,000
-60.6%
296,088
-35.5%
0.00%
-100.0%
Q2 2018$3,303,000
+494.1%
458,802
+324.7%
0.00%
Q1 2018$556,000
+1058.3%
108,023
+744.6%
0.00%
Q4 2017$48,000
+433.3%
12,790
+124.9%
0.00%
Q3 2017$9,000
-89.7%
5,687
-86.9%
0.00%
Q2 2017$87,000
-74.7%
43,506
-50.0%
0.00%
Q1 2017$344,000
-67.4%
86,970
-59.6%
0.00%
Q4 2016$1,056,000
+670.8%
215,486
+1118.4%
0.00%
Q3 2016$137,000
+114.1%
17,686
+54.1%
0.00%
Q2 2016$64,000
-20.0%
11,480
-22.2%
0.00%
Q1 2016$80,000
-69.0%
14,755
-50.2%
0.00%
Q4 2015$258,000
+106.4%
29,632
+98.8%
0.00%
Q3 2015$125,000
-95.2%
14,907
-90.0%
0.00%
-100.0%
Q2 2015$2,616,000
+1.6%
148,429
-33.4%
0.00%0.0%
Q1 2015$2,576,000
+117.6%
222,804
+89.4%
0.00%
Q4 2014$1,184,000
+11740.0%
117,645
+7743.0%
0.00%
Q2 2014$10,000
+42.9%
1,500
+160.9%
0.00%
Q1 2014$7,0005750.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 6,000,000$66,900,0002.57%
SABBY MANAGEMENT, LLC 606,298$6,760,0001.01%
Virtus ETF Advisers LLC 66,851$745,0000.39%
Newbridge Financial Services Group, Inc. 26,900$300,0000.30%
Avidian Wealth Solutions, LLC 330,000$3,680,0000.28%
Spectrum Wealth Advisory Group, LLC 36,692$422,0000.27%
COWEN AND COMPANY, LLC 129,200$1,441,0000.24%
Cormorant Asset Management, LP 500,000$5,575,0000.21%
SYMMETRY PEAK MANAGEMENT LLC 27,500$307,0000.20%
Aristides Capital LLC 24,302$271,0000.19%
View complete list of SORRENTO THERAPEUTICS INC shareholders